List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 211 studies with search of: Antihistamines for Allergies
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Condition: Allergies
Intervention:
2 Completed Olopatadine Eye Drops and Allergy Skin Testing
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Drug: olopatadine 0.2% opthalmic solution;   Drug: placebo, normal saline opthalmic solution
3 Completed To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions
Condition: Allergy
Interventions: Drug: Promethazine HCl 50 mg Tablets (Sandoz, Inc);   Drug: Phenergan (Promethazine HCl) 50 mg Tablets (Wyeth Laboratories)
4 Completed Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Olopatadine HCl Nasal Spray, 0.6%;   Drug: Azelastine HCl Nasal Spray, 0.1%
5 Not yet recruiting Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-Histamine Therapy
Condition: Urticaria
Intervention: Drug: abatacept (Orencia ®)
6 Completed The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (Study P04441)(COMPLETED)
Condition: Hypersensitivity
Interventions: Drug: desloratadine;   Drug: levocetirizine
7 Recruiting Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Veramyst /Artificial tears;   Drug: Veramyst / Artificial tears lubricant eye drops;   Drug: Veramyst nasal spray and Olopatadine eye drops;   Other: Veramyst placebo and Olopatadine0.2% eye drops
8 Completed Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
Conditions: Hay Fever;   Hypersensitivity;   Allergy;   Rhinitis
Intervention: Drug: omalizumab
9 Recruiting Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
Conditions: Allergy;   Seasonal Allergic Rhinitis;   Perennial Allergic Rhinitis
Intervention:
10 Recruiting Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
Condition: Type I - Allergy
Interventions: Biological: Grass pollen allergen extract;   Drug: symptomatic standard treatment, i.e. antihistamines and glucocorticoids as well as alphamimetics with add on placebo
11 Completed Probiotics for Birch Pollen Allergy
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: Lactobacillus acidophilus and Bifidobacterium lactis;   Biological: Placebo
12 Completed A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine and placebo;   Drug: Loratadine and Placebo;   Drug: Cetirizine and Placebo;   Drug: Placebo and Placebo (spray and Tablet)
13 Completed Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents
Condition: Allergic Reactions
Intervention: Drug: Chlorpheniramine
14 Completed Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
Condition: Allergies
Interventions: Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)
15 Completed Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
Condition: Seasonal Allergic Conjunctivitis
Intervention: Drug: Ketotifen
16 Completed To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets
Condition: Allergy
Interventions: Drug: Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.);   Drug: Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.);   Drug: Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering)
17 Completed To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
Condition: Allergy
Interventions: Drug: Clemastine Fumarate Tablets, 2.68 mg (Cord Laboratories);   Drug: Tavist Tablets, 2.68 mg (Sandoz Pharmaceutical Corp.)
18 Completed PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)
Conditions: Seasonal Allergic Rhinitis;   Hay Fever;   Rhinoconjunctivitis
Interventions: Drug: Bilastine;   Drug: Placebo
19 Completed A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms
Condition: Cat Induced Allergic Rhinitis
Intervention: Drug: Fexofenadine HCl
20 Completed Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Ciclesonide nasal spray + placebo Azelastine;   Drug: Ciclesonide nasal spray + Azelastine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services